Loading...

Home
ETF
AZN

AZN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AZN News

Foreign Healthcare Stocks Show Strong Quant Ratings

3d agoseekingalpha

Vanguard Total International Stock ETF Investment Advantages

FDA Advisory Committee Recommends AstraZeneca's Truqap for Prostate Cancer

May 01 2026seekingalpha

AstraZeneca's Cancer Drug Rejected by FDA Advisors

May 01 2026CNBC

AstraZeneca's Truqap Receives FDA Advisory Support

May 01 2026NASDAQ.COM

FDA Advisory Committee Supports TRUQAP for Prostate Cancer Treatment

May 01 2026Newsfilter

FDA Advisory Committee Supports TRUQAP for Prostate Cancer Treatment

May 01 2026Yahoo Finance

Analyst Maintains Buy Rating on AstraZeneca

Apr 30 2026stocktwits

FDA Advisory Committee Votes Against AstraZeneca's Camizestrant Approval

Apr 30 2026seekingalpha

Latest Developments in the Biotech Sector

Apr 30 2026NASDAQ.COM